R&D | April 16, 2026
NIPER Mohali, Novartis Healthcare sign pact to boost pharma R&D innovation
The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs
The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs
The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
Three-day programme equips CSIR researchers with advanced AI tools, molecular docking insights, and biomolecular simulation expertise
Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem
The acquisition aims to bolster Merck’s hematology portfolio with Terns’ lead oncology candidate, TERN-701
Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy
The patent protects antiviral compounds developed by the company that inhibit Vacuolar ATPase (V-ATPase) activity in cells, a mechanism involved in viral infection pathways
The partnership is designed to close the gap between classroom learning and real-world pharmaceutical practice
These upgrades will enable advanced development and flexible manufacturing, supporting complex therapeutics and meeting global demand for advanced pharmaceutical solutions
Subscribe To Our Newsletter & Stay Updated
